Excluding JAK2 V617F mutation analysis from the primary immune thrombocytopenia ‘diagnosis of exclusion’

Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland

Correspondence to Stephen E. Langabeer, PhD, FRCPath, Cancer Molecular Diagnostics, Trinity Translational Medicine Institute, St. James's Hospital, Dublin D08 W9RT, Ireland Tel: +353 1 4162413; e-mail: [email protected]

Received 20 September, 2022